Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 101,816	$ 119,818
Research and development tax credits receivable	684	578
Prepaid expenses	1,565	1,845
Other receivables	259	258
Total current assets	104,324	122,499
Operating lease right-of-use assets	451	524
Property and equipment	381	405
Total assets	105,156	123,428
Current liabilities
Accounts payable and accrued liabilities (note 3)	5,170	7,997
Current portion of operating lease liabilities	196	330
Total current liabilities	5,366	8,327
Operating lease liabilities	158	184
Total liabilities	5,524	8,511
Shareholders’ Equity (note 4)
Common shares, no par value, unlimited shares authorized, 24,559,470 shares issued and outstanding as of March 31, 2020, 24,505,748 shares issued and outstanding as of December 31, 2019	226,378	226,245
Additional paid-in capital	4,730	3,805
Cumulative translation adjustment	(1,634)	(1,634)
Accumulated deficit	(129,842)	(113,499)
Total shareholders’ equity	99,632	114,917
Total liabilities, and shareholders’ equity	$ 105,156	$ 123,428